On September 29, Nagoya University and Okayama University signed a university-level agreement to improve the practical application of boron neutron capture therapy (BNCT), an innovative cancer treatment method. The signing ceremony was held on Okayama University’s Tsushima Campus.

At the ceremony, invited guest Nagoya University President Seiichi Matsuo and Okayama University President Hirofumi Makino signed the agreement, and shook hands firmly while smiling.

President Matsuo said, “This agreement allows us to cooperate in leveraging the strengths of both universities—the development of neutron generators and boron delivery drugs—and integrate them organically. I have great hopes that this agreement will deepen our efforts to work together and improve BNCT’s practicality.”

President Makino said, “BNCT is gaining attention as a therapy for malignant tumors, which have been considered difficult to treat. It also holds great promise for treating a variety of cancer in the future. I want both universities to further proceed with joint research and advance the state of BNCT.”

Nagoya University and Okayama University seek to carry out deeper joint research going forward and also collaborate with the International Atomic Energy Agency (IAEA) and other research organizations to establish world standards for BNCT.